ABUS

#2131
Arbutus Biopharma Corporation - Common Stock
4.5 6 USD
-0.87%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
4.53
4.58
Faixa anual
3.04
5.10
Mudança diária
-0.87%
Mudança mensal
+10.41%
Mudança em 6 meses
+5.07%
Mudança anual
+33.33%
Fechamento anterior
4.6 0
Open
4.5 7
Mínimo
4.5 3
High
4.5 8
Volume
635
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
  • Market Capitalization 900.77 M
  • Employee 19
  • Founded 2007
  • CEO William H. Collier
  • Website www.arbutusbio.com
  • Headquarter British Columbia, Canada
  • FIGI BBG000RR8V85
  • Industry Biotecnologia
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
-28.29
Índice preço/fluxo de caixa
65.44

Arbutus Biopharma Corporation - Common Stock

Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007.

Notícias